AEGIR.ST Gross Margin

The Gross Margin of Aegirbio AB (AEGIR.ST) is 47.83%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

AEGIR.ST Gross Margin - Historical Value

Date	Value
2023-12-31	47.83%
2022-12-31	-1389.57%
2021-12-31	41.48%

AEGIR.ST Gross Margin - Peers Comparison

Ticker	Name	Value
MVIR B.ST	Medivir AB	-1470.45%
PUR.WA	Pure Biologics SA	-2709.47%
ABNX.PA	Abionyx Pharma SA	18.35%
ACTI.ST	Active Biotech AB publ	100.00%
LIDDS.ST	Lidds AB	-1102.81%
SPRINT.ST	Sprint Bioscience AB	56.83%
ALLR.ST	Allarity Therapeutics A/S	-175.91%
ALPAT.PA	Plant Advanced Technologies PAT SA	128.03%
BONEX.ST	Bonesupport Holding AB	92.60%
RDG.WA	Read Gene SA	93.23%
MTPH.L	Midatech Pharma PLC	94.91%
T5O.DE	bioXXmed AG	100.00%
TOL.ST	Toleranzia AB	1842.86%
IMMU.ST	Mendus AB (publ)	7775.20%
VITR.ST	Vitrolife AB	59.27%
ALPRE.PA	Predilife SA	97.25%
EVG.L	Evgen Pharma PLC	-1151.58%
GUARD.ST	Guard Therapeutics International AB (publ)	100.00%
IVACC.ST	Intervacc AB	-29.92%
PROMO.ST	Promore Pharma AB	-124472.22%
XINT.ST	Xintela AB	100.00%
ALNEV.PA	Neovacs SA	5.49%
ATORX.ST	Alligator Bioscience AB	-312.94%
GEN.WA	Genomed SA	44.96%
GV.PA	Genomic Vision SA	-165.01%
BIOG B.ST	Biogaia AB	72.45%
HNSA.ST	Hansa Biopharma AB	51.23%
IDOGEN.ST	Idogen AB	7775.20%
VAL.L	ValiRx PLC	85.00%
PROB.ST	Probi AB	35.08%
SCS.WA	Stem Cells Spin SA	86.16%
SENZA.ST	SenzaGen AB	66.89%
SOBI.ST	Swedish Orphan Biovitrum AB (publ)	78.03%
BIOA B.ST	BioArctic AB	89.51%
XBRANE.ST	Xbrane Biopharma AB	90.83%